{"id":2903,"date":"2024-12-20T13:46:31","date_gmt":"2024-12-20T10:46:31","guid":{"rendered":"https:\/\/www.sightsciences.com\/us\/?page_id=2903"},"modified":"2025-10-17T17:42:11","modified_gmt":"2025-10-17T14:42:11","slug":"fairaccess","status":"publish","type":"page","link":"https:\/\/www.sightsciences.com\/us\/tearcare\/fairaccess\/","title":{"rendered":"Fair access"},"content":{"rendered":"","protected":false},"excerpt":{"rendered":"","protected":false},"author":2,"featured_media":4416,"parent":2812,"menu_order":25,"comment_status":"closed","ping_status":"closed","template":"templates\/tearcare-page-fairaccess.php","meta":{"_acf_changed":false,"footnotes":""},"class_list":["post-2903","page","type-page","status-publish","has-post-thumbnail","hentry"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v27.1 (Yoast SEO v27.1.1) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>MGD Fair access - United States<\/title>\n<meta name=\"description\" content=\"Patients should have insured access to interventional therapy for MGD AND Doctors should receive fair reimbursement for that therapy.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.sightsciences.com\/us\/tearcare\/fairaccess\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Fair access\" \/>\n<meta property=\"og:description\" content=\"Patients should have insured access to interventional therapy for MGD AND Doctors should receive fair reimbursement for that therapy.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.sightsciences.com\/us\/tearcare\/fairaccess\/\" \/>\n<meta property=\"og:site_name\" content=\"United States\" \/>\n<meta property=\"article:modified_time\" content=\"2025-10-17T14:42:11+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.sightsciences.com\/us\/wp-content\/uploads\/sites\/4\/2025\/04\/featured_image_1200_630.png\" \/>\n\t<meta property=\"og:image:width\" content=\"1200\" \/>\n\t<meta property=\"og:image:height\" content=\"630\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.sightsciences.com\/us\/tearcare\/fairaccess\/\",\"url\":\"https:\/\/www.sightsciences.com\/us\/tearcare\/fairaccess\/\",\"name\":\"MGD Fair access - United States\",\"isPartOf\":{\"@id\":\"https:\/\/www.sightsciences.com\/us\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.sightsciences.com\/us\/tearcare\/fairaccess\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.sightsciences.com\/us\/tearcare\/fairaccess\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.sightsciences.com\/us\/wp-content\/uploads\/sites\/4\/2025\/04\/featured_image_1200_630.png\",\"datePublished\":\"2024-12-20T10:46:31+00:00\",\"dateModified\":\"2025-10-17T14:42:11+00:00\",\"description\":\"Patients should have insured access to interventional therapy for MGD AND Doctors should receive fair reimbursement for that therapy.\",\"breadcrumb\":{\"@id\":\"https:\/\/www.sightsciences.com\/us\/tearcare\/fairaccess\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.sightsciences.com\/us\/tearcare\/fairaccess\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.sightsciences.com\/us\/tearcare\/fairaccess\/#primaryimage\",\"url\":\"https:\/\/www.sightsciences.com\/us\/wp-content\/uploads\/sites\/4\/2025\/04\/featured_image_1200_630.png\",\"contentUrl\":\"https:\/\/www.sightsciences.com\/us\/wp-content\/uploads\/sites\/4\/2025\/04\/featured_image_1200_630.png\",\"width\":1200,\"height\":630},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.sightsciences.com\/us\/tearcare\/fairaccess\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.sightsciences.com\/us\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Tearcare\",\"item\":\"https:\/\/www.sightsciences.com\/us\/tearcare\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Fair access\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.sightsciences.com\/us\/#website\",\"url\":\"https:\/\/www.sightsciences.com\/us\/\",\"name\":\"United States\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.sightsciences.com\/us\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"MGD Fair access - United States","description":"Patients should have insured access to interventional therapy for MGD AND Doctors should receive fair reimbursement for that therapy.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.sightsciences.com\/us\/tearcare\/fairaccess\/","og_locale":"en_US","og_type":"article","og_title":"Fair access","og_description":"Patients should have insured access to interventional therapy for MGD AND Doctors should receive fair reimbursement for that therapy.","og_url":"https:\/\/www.sightsciences.com\/us\/tearcare\/fairaccess\/","og_site_name":"United States","article_modified_time":"2025-10-17T14:42:11+00:00","og_image":[{"width":1200,"height":630,"url":"https:\/\/www.sightsciences.com\/us\/wp-content\/uploads\/sites\/4\/2025\/04\/featured_image_1200_630.png","type":"image\/png"}],"twitter_card":"summary_large_image","twitter_misc":{"Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.sightsciences.com\/us\/tearcare\/fairaccess\/","url":"https:\/\/www.sightsciences.com\/us\/tearcare\/fairaccess\/","name":"MGD Fair access - United States","isPartOf":{"@id":"https:\/\/www.sightsciences.com\/us\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.sightsciences.com\/us\/tearcare\/fairaccess\/#primaryimage"},"image":{"@id":"https:\/\/www.sightsciences.com\/us\/tearcare\/fairaccess\/#primaryimage"},"thumbnailUrl":"https:\/\/www.sightsciences.com\/us\/wp-content\/uploads\/sites\/4\/2025\/04\/featured_image_1200_630.png","datePublished":"2024-12-20T10:46:31+00:00","dateModified":"2025-10-17T14:42:11+00:00","description":"Patients should have insured access to interventional therapy for MGD AND Doctors should receive fair reimbursement for that therapy.","breadcrumb":{"@id":"https:\/\/www.sightsciences.com\/us\/tearcare\/fairaccess\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.sightsciences.com\/us\/tearcare\/fairaccess\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.sightsciences.com\/us\/tearcare\/fairaccess\/#primaryimage","url":"https:\/\/www.sightsciences.com\/us\/wp-content\/uploads\/sites\/4\/2025\/04\/featured_image_1200_630.png","contentUrl":"https:\/\/www.sightsciences.com\/us\/wp-content\/uploads\/sites\/4\/2025\/04\/featured_image_1200_630.png","width":1200,"height":630},{"@type":"BreadcrumbList","@id":"https:\/\/www.sightsciences.com\/us\/tearcare\/fairaccess\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.sightsciences.com\/us\/"},{"@type":"ListItem","position":2,"name":"Tearcare","item":"https:\/\/www.sightsciences.com\/us\/tearcare\/"},{"@type":"ListItem","position":3,"name":"Fair access"}]},{"@type":"WebSite","@id":"https:\/\/www.sightsciences.com\/us\/#website","url":"https:\/\/www.sightsciences.com\/us\/","name":"United States","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.sightsciences.com\/us\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"}]}},"_links":{"self":[{"href":"https:\/\/www.sightsciences.com\/us\/wp-json\/wp\/v2\/pages\/2903","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.sightsciences.com\/us\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.sightsciences.com\/us\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.sightsciences.com\/us\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.sightsciences.com\/us\/wp-json\/wp\/v2\/comments?post=2903"}],"version-history":[{"count":4,"href":"https:\/\/www.sightsciences.com\/us\/wp-json\/wp\/v2\/pages\/2903\/revisions"}],"predecessor-version":[{"id":5485,"href":"https:\/\/www.sightsciences.com\/us\/wp-json\/wp\/v2\/pages\/2903\/revisions\/5485"}],"up":[{"embeddable":true,"href":"https:\/\/www.sightsciences.com\/us\/wp-json\/wp\/v2\/pages\/2812"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.sightsciences.com\/us\/wp-json\/wp\/v2\/media\/4416"}],"wp:attachment":[{"href":"https:\/\/www.sightsciences.com\/us\/wp-json\/wp\/v2\/media?parent=2903"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}